GE HealthCare claimed European approval for a compact cyclotron designed for the local production of rapidly decaying PET ...

GE HealthCare (Nasdaq: GEHC) today announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for ...

GE HealthCare Technologies (GEHC) said Thursday its MINItrace Magni cyclotron has achieved the CE mark, while its PETtrace Solid Target Platform is expanding beyond gallium-68. The company said the ...

Two men arrested in Navi Mumbai for a fake iridium investment scheme duping about 300 investors of ₹4–5 lakh each.

Actinium Pharmaceuticals (NYSE American: ATNM), a developer of targeted radiotherapies for cancer treatment, has appointed ...

ATNM-400 is a first-in-class, non-PSMA targeted radiotherapy being developed to address a broad mCRPC patient population, including PSMA-low and PSMA-negative disease and patients who do not respond ...

A Florida State University-led review shows how ultrahigh-resolution mass spectrometry can help researchers identify the ...

A Kuwaiti PET imaging study of 292 patients found that people with prior cardiac disease had significantly lower absolute ...

Actinium Pharmaceuticals, Inc.  (NYSE American: ATNM) ("Actinium" or the "Company"), a pioneer in the development of targeted radiotherapies, today announced the appointment of Matt David, M.D., as ...

GE HealthCare announced that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 (64Cu) production. For those seeking to broaden their production capabilities, ...

A Florida State University-led review shows how ultrahigh-resolution mass spectrometry can help researchers identify the molecular fingerprints of ...

Wendelstein 7-X begins OP2.4, a 12-week campaign focused on high-performance plasmas, fast ions and long pulses.